The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Tranilast: A review of its therapeutic applications
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Diabetes and Cardiovascular Disease: The Framingham Study
Kannel, W. B. (1979) · JAMA · doi:10.1001/jama.1979.03290450033020 · Cited by 2,936
TGFβ Signaling in Growth Control, Cancer, and Heritable Disorders
Massagué, J., Blain, S. W., & Lo, R. S. (2000) · Cell · doi:10.1016/s0092-8674(00)00121-5 · Cited by 2,385
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
Li, M. O., Wan, Y. Y., Sanjabi, S., Robertson, A.-K. L., & Flavell, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.24.021605.090737 · Cited by 2,206
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Opitz, C. A., Litzenburger, U. M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al. (2011) · Nature · doi:10.1038/nature10491 · Cited by 1,898
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Fang, Z. Y., Prins, J. B., & Marwick, T. H. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0012 · Cited by 912
The long-term course of cyclosporine-associated chronic nephropathy
Myers, B. D., Sibley, R., Newton, L., Tomlanovich, S. J., Boshkos, C., Stinson, E., Luetscher, J. A., Whitney, D. J., Krasny, D., Coplon, N. S., et al. (1988) · Kidney International · doi:10.1038/ki.1988.38 · Cited by 506
A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours
Beck, B., Driessens, G., Goossens, S., Youssef, K. K., Kuchnio, A., Caauwe, A., Sotiropoulou, P. A., Loges, S., Lapouge, G., Candi, A., et al. (2011) · Nature · doi:10.1038/nature10525 · Cited by 467
Treatment of Autoimmune Neuroinflammation with a Synthetic Tryptophan Metabolite
Platten, M., Ho, P. P., Youssef, S., Fontoura, P., Garren, H., Hur, E. M., Gupta, R., Lee, L. Y., Kidd, B. A., Robinson, W. H., et al. (2005) · Science · doi:10.1126/science.1117634 · Cited by 425
Prud'homme, G. J. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700669 · Cited by 419
Latent TGF-β Binding Proteins: Extracellular Matrix Association and Roles in TGF-β Activation
Hyytiäinen, M., Penttinen, C., & Keski-Oja, J. (2004) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360490460933 · Cited by 354
TRPV2 has a pivotal role in macrophage particle binding and phagocytosis
Link, T. M., Park, U., Vonakis, B. M., Raben, D. M., Soloski, M. J., & Caterina, M. J. (2010) · Nature Immunology · doi:10.1038/ni.1842 · Cited by 323
Bentley, A. M., Jacobson, M. R., Cumberworth, V., Barkans, J. R., Moqbel, R., Schwartz, L. B., Irani, A.-M. A., Kay, A. B., & Durham, S. R. (1992) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(92)90444-7 · Cited by 274
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial
Holmes, D. R., Savage, M., LaBlanche, J.-M., Grip, L., Serruys, P. W., Fitzgerald, P., Fischman, D., Goldberg, S., Brinker, J. A., Zeiher, A. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000028335.31300.da · Cited by 260
Purification and characterization of rat brain prostaglandin D synthetase.
Urade, Y., Fujimoto, N., & Hayaishi, O. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38889-0 · Cited by 242
Expression of Transforming Growth Factor Beta 1, 2, and 3 Proteins in Keloids
Lee, T. Y., Chin, G. S., Kim, W. J. H., Chau, D., Gittes, G. K., & Longaker, M. T. (1999) · Annals of Plastic Surgery · doi:10.1097/00000637-199908000-00013 · Cited by 239
Evidence for a Role of Mast Cells in the Evolution to Congestive Heart Failure
Hara, M., Ono, K., Hwang, M.-W., Iwasaki, A., Okada, M., Nakatani, K., Sasayama, S., & Matsumori, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20002036 · Cited by 239
NF-κB pathway inhibitors preferentially inhibit breast cancer stem-like cells
Zhou, J., Zhang, H., Gu, P., Bai, J., Margolick, J. B., & Zhang, Y. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9798-y · Cited by 201
SUZAWA, H., Kikuchi, S., Arai, N., & Koda, A. (1992) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.60.91 · Cited by 199
ZHANG, D., SPIELMANN, A., WANG, L., DING, G., HUANG, F., GU, Q., & SCHWARZ, W. (2012) · Physiological Research · doi:10.33549/physiolres.932053 · Cited by 199
Lindstedt, K. A., Wang, Y., Shiota, N., Saarinen, J., Hyytiäinen, M., Kokkonen, J. O., Keski-Oja, J., & Kovanen, P. T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0273com · Cited by 197
Regulation of Calcium-Permeable TRPV2 Channel by Insulin in Pancreatic β-Cells
Hisanaga, E., Nagasawa, M., Ueki, K., Kulkarni, R. N., Mori, M., & Kojima, I. (2008) · Diabetes · doi:10.2337/db08-0862 · Cited by 173
Diabetic Nephropathy: Worldwide epidemic and effects of current treatment on natural history
Rossing, P. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0083-y · Cited by 170
Expression of Transforming Growth Factor Beta 1, 2, and 3 Proteins in Keloids
Lee, T. Y., Chin, G. S., Kim, W. J. H., Chau, D., Gittes, G. K., & Longaker, M. T. (1999) · Annals of Plastic Surgery · doi:10.1097/00000637-199943020-00013 · Cited by 169
Iwata, Y., Katanosaka, Y., Arai, Y., Shigekawa, M., & Wakabayashi, S. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn408 · Cited by 153
Cancer Stem Cells and Novel Targets for Antitumor Strategies
Prud’homme, G. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800626120 · Cited by 150
Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
Prud’homme, G. J., Glinka, Y., Toulina, A., Ace, O., Subramaniam, V., & Jothy, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013831 · Cited by 143
Role of transforming growth factor-β in the progression of heart failure
Lim, H., & Zhu, Y. Z. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6085-8 · Cited by 136
Tranilast, a Selective Inhibitor of Collagen Synthesis in Human Skin Fibroblasts
Yamada, H., Tajima, S., Nishikawa, T., Murad, S., & Pinnell, S. R. (1994) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a124612 · Cited by 134
Biochemical and immunological characterization of rat spleen prostaglandin D synthetase.
Urade, Y., Fujimoto, N., Ujihara, M., & Hayaishi, O. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61429-2 · Cited by 133
Tamai, H., Katoh, O., Suzuki, S., Fujii, K., Aizawa, T., Takase, S., Kurogane, H., Nishikawa, H., Sone, T., Sakai, K., et al. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70025-6 · Cited by 130
Martin, J. H., Kelly, D. J., Mifsud, S., ZHANG, Y., COX, A., See, F. H. W., Krum, H., Wilkinson‐Berka, J. L., & Gilbert, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.10.041 · Cited by 116
Santoni, G., Farfariello, V., Liberati, S., Morelli, M. B., Nabissi, M., Santoni, M., & Amantini, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00034 · Cited by 115
Miyazawa, K., Kikuchi, S., Fukuyama, J., Hamano, S., & Ujiie, A. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05607-6 · Cited by 108
CXCL 9 and CXCL 10 as Sensitive Markers of Disease Activity in Patients with Rheumatoid Arthritis
Kuan, W.-P., Tam, L., Wong, C. K., Ko, F. W. S., Li, T., ZHU, T. Y., & Li, E. K. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090769 · Cited by 105
Isaji, M., Miyata, H., Ajisawa, Y., Takehana, Y., & Yoshimura, N. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701493 · Cited by 100
Insulin Resistance as a Proinflammatory State: Mechanisms, Mediators, and Therapeutic Interventions
Garg, R., Tripathy, D., & Dandona, P. (2003) · Current Drug Targets · doi:10.2174/1389450033490920 · Cited by 95
The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy
Zhang, S. J., Lei, P., Liu, X., Li, X., Walker, K., Kotha, L., Rowlands, C., & Safe, S. H. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0054 · Cited by 94
Platten, M., Wild‐Bode, C., Wick, W., Leitlein, J., DICHGANS, J., & Weller, M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1289 · Cited by 91
Blockade of sarcolemmal TRPV2 accumulation inhibits progression of dilated cardiomyopathy
Iwata, Y., Ohtake, H., Suzuki, O., Matsuda, J., Komamura, K., & Wakabayashi, S. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt163 · Cited by 87
Arias, M., Sauer-Lehnen, S., Treptau, J., Janoschek, N., Theuerkauf, I., Buettner, R., Gressner, A. M., & Weiskirchen, R. (2003) · BMC Gastroenterology · doi:10.1186/1471-230x-3-29 · Cited by 81
Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca2+-permeable channel
Nie, L., Oishi, Y., Doi, I., Shibata, H., & Kojima, I. (1997) · Cell Calcium · doi:10.1016/s0143-4160(97)90107-x · Cited by 81
Pinto, Y. M., Pinto‐Sietsma, S., Philipp, T., Engler, S., Koβmehl, P., Hocher, B., Marquardt, H., Sethmann, S., Lauster, R., Merker, H., et al. (2000) · Hypertension · doi:10.1161/01.hyp.36.5.747 · Cited by 80
Isaji, M., Nakajoh, M., & Naito, J. (1987) · Biochemical Pharmacology · doi:10.1016/0006-2952(87)90353-4 · Cited by 79
Holmes, D. R., Fitzgerald, P. J., Goldberg, S., Lablanche, J. M., Lincoff, A. M., Savage, M. P., Serruys, P. W. J. C., Willerson, J. T., Granett, J. R., Chan, R. H., et al. (2000) · American Heart Journal · doi:10.1016/s0002-8703(00)90304-1 · Cited by 78
Shiota, N., Okunishi, H., Takai, S., Mikoshiba, I., Sakonjo, H., Shibata, N., & Miyazaki, M. (1999) · Circulation · doi:10.1161/01.cir.99.8.1084 · Cited by 74
Tranilast Attenuates Structural and Functional Aspects of Renal Injury in the Remnant Kidney Model
Kelly, D. J., Zhang, Y., Gow, R. M., & Gilbert, R. E. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000139066.77892.04 · Cited by 74
Ward, M. R., Sasahara, T., Agrotis, A., Dilley, R. J., Jennings, G., & Bobik, A. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00275-x · Cited by 71
Suppression of laser-induced choroidal neovascularization by oral tranilast in the rat.
Takehana, Y., Kurokawa, T., Kitamura, T., Tsukahara, Y., Akahane, S., Kitazawa, M., & Yoshimura, N. (1999) · PubMed · Cited by 70
Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis†
Uno, M., Kurita, S., Misu, H., Ando, H., Ota, T., Nagata, N., Kita, Y., Nabemoto, S., Akahori, H., Zen, Y., et al. (2008) · Hepatology · doi:10.1002/hep.22338 · Cited by 70
Inglis, J. J., Criado, G., Andrews, M. R., Feldmann, M., Williams, R. O., & Selley, M. L. (2007) · Rheumatology · doi:10.1093/rheumatology/kem160 · Cited by 67
Tranilast inhibits the growth and metastasis of mammary carcinoma
Chakrabarti, R., Subramaniam, V., Abdalla, S. A., Jothy, S., & Prud’homme, G. J. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328327994e · Cited by 66
Takahashi, A., Taniguchi, T., Ishikawa, Y., & Yokoyama, M. (1999) · Circulation Research · doi:10.1161/01.res.84.5.543 · Cited by 66
Kojima, I., & Nagasawa, M. (2014) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-54215-2_10 · Cited by 66
Furness, S. G. B., & Whelan, F. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.004 · Cited by 63
Tamai, H., Katoh, K., Yamaguchi, T., Hayakawa, H., Kanmatsuse, K., Haze, K., Aizawa, T., Nakanishi, S., Suzuki, S., Suzuki, T., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120770 · Cited by 61
Nakatani, Y., Nishida, K., Sakabe, M., Kataoka, N., Sakamoto, T., Yamaguchi, Y., Iwamoto, J., Mizumaki, K., Fujiki, A., & Inoue, H. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.014 · Cited by 61
Tranilast Inhibits Cytokine-Induced Nuclear Factor κB Activation in Vascular Endothelial Cells
Spiecker, M., Lorenz, I., Marx, N., & Darius, H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.856 · Cited by 61
Kelly, D. J., Zhang, Y., Connelly, K. A., Cox, A. J., Martin, J. H., Krum, H., & Gilbert, R. E. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01167.2006 · Cited by 60
Okuda, M., Ishikawa, T., SAITO, Y., Shimizu, T., & Baba, S. (1984) · PubMed · Cited by 58
Tranilast Slows the Progression of Advanced Diabetic Nephropathy
Soma, J., Sugawara, T., Huang, Y.-D., et al. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000064071 · Cited by 55
Izumi, K., Mizokami, A., Li, Y. Q., Narimoto, K., Sugimoto, K., Kadono, Y., Kitagawa, Y., Konaka, H., Koh, E., Keller, E. T., et al. (2009) · The Prostate · doi:10.1002/pros.20975 · Cited by 54
Fukuyama, J., Miyazawa, K., Hamano, S., & Ujiie, A. (1996) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y95-230 · Cited by 53
Fleisch, M. C., Maxwell, C. A., & Barcellos-Hoff, M.-H. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01112 · Cited by 52
Ward, M. R., Agrotis, A., Kanellakis, P., Hall, J., Jennings, G., & Bobik, A. (2002) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000019405.84384.9c · Cited by 50
Effect of tranilast on matrix metalloproteinase production from neutrophils in-vitro
Shimizu, T., Kanai, K., Kyo, Y., Suzaki, H., Asano, K., & Hisamitsu, T. (2005) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.1.0011 · Cited by 49
Tan, S. M., Zhang, Y., Cox, A. J., Kelly, D. J., & Qi, W. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq355 · Cited by 49
Effect of tranilast in early-stage diabetic nephropathy
Soma, J., Satô, K., Saito, H., & Tsuchiya, Y. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfl325 · Cited by 48
Isaji, M., Aruga, N., Naito, J., & Miyata, H. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00668-7 · Cited by 47
Chikaraishi, A., Hirahashi, J., Takase, O., Marumo, T., Hishikawa, K., Hayashi, M., & Saruta, T. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01215-8 · Cited by 46
Mori, H., Tanaka, H., Kawada, K., Nagai, H., & Koda, A. (1995) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.67.279 · Cited by 45
Ishiwata, S., Verheye, S., Robinson, K. A., Salame, M. Y., León, H. D., King, S. B., & Chronos, N. A. F. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00528-3 · Cited by 44
Subramaniam, V., Ace, O., Prud’homme, G. J., et al. (2010) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2010.10.012 · Cited by 42
Kaneyama, T., Kobayashi, S., Aoyagi, D., & Ehara, T. (2010) · Pathology · doi:10.3109/00313025.2010.508784 · Cited by 40
Jones, S. E., Gilbert, R. E., & Kelly, D. J. (2004) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2004.02.002 · Cited by 40
Hertenstein, A., Schumacher, T., Litzenburger, U. M., Opitz, C. A., Falk, C. S., Serafini, T. A., Wick, W., & Platten, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.013 · Cited by 37
TRANILAST AMELIORATES RENAL TUBULAR DAMAGE IN UNILATERAL URETERAL OBSTRUCTION
Miyajima, A., Asano, T., Asano, T., Yoshimura, I., Seta, K., & Hayakawa, M. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66400-2 · Cited by 37
Shiota, N., Kovanen, P. T., Eklund, K., Shibata, N., Shimoura, K., Niibayashi, T., Shimbori, C., & Okunishi, H. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00561.x · Cited by 36
Koyama, S., Takagi, H., Otani, A., Suzuma, K., Nishimura, K., & Honda, Y. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702564 · Cited by 35
Tranilast enhances the anti-tumor effects of tamoxifen on human breast cancer cells in vitro
Darakhshan, S., & Ghanbari, A. (2013) · Journal of Biomedical Science · doi:10.1186/1423-0127-20-76 · Cited by 34
Self-citationCapper, E. A., Roshak, A., Bolognese, B. J., Podolin, P. L., Smith, T., DeWitt, D. L., Anderson, K. M., & Marshall, L. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39006-8 · Cited by 34
Noguchi, N., Kawashiri, S., Tanaka, A., Kato, K., & Nakaya, H. (2003) · Oral Oncology · doi:10.1016/s1368-8375(02)00092-1 · Cited by 32
Shimizu, T., Kanai, K., Asano, K., Hisamitsu, T., & Suzaki, H. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.150 · Cited by 32
Nie, L., Mogami, H., Kanzaki, M., Shibata, H., & Kojima, I. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09376-9 · Cited by 31
Yamada, H. (1995) · Journal of Dermatological Science · doi:10.1016/0923-1811(94)00355-i · Cited by 31
Oshima, T., Kurosaka, D., Kato, K., Kurosaka, H., Mashima, Y., Tanaka, Y., & Tajima, S. (2000) · Current Eye Research · doi:10.1076/0271-3683(200004)2041-5ft283 · Cited by 30
Tranilast Kissei Pharmaceutical.
Konneh, M. (1998) · PubMed · Cited by 27
Darakhshan, S., Bidmeshkipour, A., Khazaei, M., et al. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.11.6869 · Cited by 27
Self-citationKelly, D. J., Zhang, Y., Cox, A. J., & Gilbert, R. E. (2006) · Kidney International · doi:10.1038/sj.ki.5000376 · Cited by 26
Platten, M., Wick, W., Wischhusen, J., & Weller, M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704373 · Cited by 26
Transforming Growth Factor-β, Smads, and Cancer
Grady, W. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0414 · Cited by 25
Platten, M., Eitel, K., Wischhusen, J., DICHGANS, J., & Weller, M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00449-0 · Cited by 25
Isaji, M., Kikuchi, S., Miyata, H., Ajisawa, Y., Araki-Inazawa, K., Tsukamoto, Y., & Amano, Y. (2000) · Cornea · doi:10.1097/00003226-200005000-00021 · Cited by 24
Isaji, M., Miyata, H., Ajisawa, Y., et al. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00277-x · Cited by 20
Kondo, N., Fukutomi, O., Kameyama, T., & Orii, T. (1992) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1992.tb00146.x · Cited by 18
Tranilast suppresses prostate cancer growth and osteoclast differentiation in vivo and in vitro
Sato, S., Takahashi, S., Asamoto, M., Naiki, T., Naiki‐Ito, A., Asai, K., & Shirai, T. (2009) · The Prostate · doi:10.1002/pros.21056 · Cited by 17
Nagate, T., Tamura, T., Sato, F., Kuroda, J., Nakayama, J., & Shibata, N. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0070534 · Cited by 16
Tranilast: A novel weapon against insulin resistance
Namazi, M. R., & Soma, J. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2003.11.047 · Cited by 14
Fan, J., Stanfield, J., Guo, Y., Karam, J. A., Frenkel, E. P., Sun, X., & Hsieh, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1656 · Cited by 13
Inhibition by tranilast of nifedipine-induced proliferation of cultured human gingival fibroblasts
Hattori, T., & Wang, P. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.061 · Cited by 12
Yang, X., Feng, L., Li, C., & Li, Y. (2013) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13151fp · Cited by 12
Okamoto, S. (1999) · Japanese Journal of Ophthalmology · doi:10.1016/s0021-5155(99)00103-3 · Cited by 12
Nakajima, K., Okita, Y., & Matsuda, S. (2004) · Oncology Reports · doi:10.3892/or.12.1.85 · Cited by 10
Cited by
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
Swanson, K. V., Deng, M., & Ting, J. P.-Y. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0165-0 · Cited by 4,884
Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang, Y., Wang, H., Kouadir, M., Song, H., & Shi, F. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1413-8 · Cited by 1,269
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Paik, S., Kim, J. K., Silwal, P., Sasakawa, C., & Jo, E.-K. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00670-3 · Cited by 892
Pharmacological Inhibitors of the NLRP3 Inflammasome
Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02538 · Cited by 671
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Du, L., Zong, Y., Li, H., Wang, Q., Xie, L., Yang, B., Pang, Y., Zhang, C., Zhong, Z., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01916-y · Cited by 631
Metadata
- Authors
- Darakhshan, S., & Pour, A. B.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 91
- Pages
- 15-28
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2076992552
- Cited by
- 322
- References
- 103
- FWCI
- 2.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.